Castleview Partners’s Embecta EMBC Stock Holding History

Castleview Partners’s Portfolio EMBC Stock Details EMBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10	Closed	-$252	–	680
2022 Q4	$252	Buy	+10	New	+$305	﹤0.01%	608

Other funds holding EMBC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

YAM

Yacktman Asset Management Austin, Texas $8.09B AUM 19.03% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Castleview Partners's EMBC Position: Q1 2023 in Review

Castleview Partners sold out of Embecta (EMBC) in Q1 2023, closing a stake of 10 shares — an estimated $252 sold.

Castleview Partners first reported a position in EMBC in Q4 2022 and held it in 1 quarter. The position peaked at $252 in Q4 2022. 433 funds tracked by Wall St. Rank hold EMBC as of Q1 2023.

Castleview Partners reported no remaining Embecta position as of Q1 2023 after selling out during the quarter.
Castleview Partners sold 10 Embecta shares in Q1 2023, an estimated $252.
Castleview Partners first reported a position in Embecta in Q4 2022 and held it in 1 quarter.
Castleview Partners's Embecta position peaked at $252 in Q4 2022.
433 funds tracked by Wall St. Rank held Embecta as of Q1 2023.

Based on Castleview Partners's 13F filing for Q1 2023, filed 16 May 2023.